Evidence map›Paper›PMID 36936213›Full record

ArticleFrontiers in medicine2023

Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States.

Ilona Argirion, Parag Mahale, Ruth M Pfeiffer, Ping Liu, Adaora A Adimora, Matthew J Akiyama, Hector H Bolivar, Audrey French, Michael Plankey, Jennifer C Price and 7 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 1 country.

Ilona ArgirionInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Parag MahaleInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Ruth M PfeifferBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Ping LiuDepartment of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, United States.
Adaora A AdimoraSchool of Medicine and University of North Carolina Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Matthew J AkiyamaDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Montefiore Health System, Bronx, NY, United States.
Hector H BolivarDepartment of Medicine, University of Miami Health System, Miami, FL, United States.
Audrey FrenchDivision of Neurology, Cook County Health, Chicago, IL, United States.
Michael PlankeyDepartment of Medicine, Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC, United States.
Jennifer C PriceDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Aadia RanaDivision of Infectious Diseases, University of Alabama-Birmingham Heersink School of Medicine, Birmingham, AL, United States.
Anandi ShethDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, United States.
Jill KoshiolInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Eric C SeabergDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Mark H KuniholmDepartment of Epidemiology and Biostatistics, University at Albany, State University of New York, Rensselaer, NY, United States.
Jeffrey GlennDepartment of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, United States.
Thomas R O'BrienInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Division of Cancer Epidemiology and GeneticsStanford University · USAlbany State University · USAlbert Einstein College of Medicine · USCook County Health and Hospitals System · USEmory University · USGeorgetown University · USJohns Hopkins University · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Miami Health System · USUniversity of North Carolina at Chapel Hill · US

Funding

MWCCS: Brooklyn Clinical Research SiteU01HL146202 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI TRACEY ELIZABETH WILSON, Jessica Eve Yager · 2019 to 2026
$23.6M
NHLBI NIH HHS U01 HL146202
6 · The paper itself

Abstract

Hepatitis D virus (HDV) requires co-infection with hepatitis B virus (HBV). Human immunodeficiency virus (HIV) shares transmission routes with these viruses. Among 4,932 US women infected with or at-risk for HIV during 1994-2015, HBV surface antigen (HBsAg) positivity was more common in women with HIV (2.8% vs. 1.2%;

Indexed as

anti-HDVepidemiologyhepatitis B virushepatitis C virushepatitis D viruspersons who injected drugs

Identifiers

PMID36936213
PMCPMC10017733
OpenAlexW4322772769

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read66
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.